US seizes unapproved drugs from KV Pharmaceutical - updated
This article was originally published in Scrip
Executive Summary
US federal agents have seized more than 20 formulations of unapproved drug products made by KV Pharmaceuticalin conjunction with an ongoing FDA crackdown on the sale of such medicines. The government valued the amount seized at $24.2 million, but KV says the full value of the inventory was $5.5 million and was written-off earlier this year.